Come up with a name for your new list and we'll add to it:
Karyopharm Therapeutics raised a round of funding on January 06, 2011. Investors include
Multiple Myeloma Research Foundation.
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing small molecule modulators of nuclear transport. Karyopharm's selective inhibitors of nuclear export (SINE) function by tra…